ECM
IDXX icon

ExodusPoint Capital Management’s Idexx Laboratories IDXX Stock Holding History

ExodusPoint Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,000
Closed -$1.26M – 2353
2021
Q2 		$1.26M Buy
+2,000
New +$1.1M 0.01% 883

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ExodusPoint Capital Management's IDXX Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 22,386 shares — an estimated $15.1M sold.

ExodusPoint Capital Management first reported a position in IDXX in Q4 2018 and held it in 15 quarters. The position peaked at $23.1M in Q4 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 22,386 Idexx Laboratories shares in Q1 2026, an estimated $15.1M.
  • ExodusPoint Capital Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 15 quarters.
  • ExodusPoint Capital Management's Idexx Laboratories position peaked at $23.1M in Q4 2024.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.